Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$454K Buy
6,042
+10
+0.2% +$761 0.03% 99
2021
Q2
$469K Sell
6,032
-1,192
-17% -$88.7K 0.03% 95
2021
Q1
$531K Buy
7,224
+493
+7% +$36.4K 0.03% 92
2020
Q4
$525K Buy
6,731
+97
+1% +$7.42K 0.03% 88
2020
Q3
$525K Buy
6,634
+712
+12% +$55.8K 0.04% 81
2020
Q2
$437K Sell
5,922
-1,258
-18% -$94.7K 0.03% 82
2020
Q1
$527K Buy
7,180
+4,376
+156% +$344K 0.05% 74
2019
Q4
$243K Hold
2,804
0.02% 121
2019
Q3
$225K Sell
2,804
-86
-3% -$6.89K 0.02% 126
2019
Q2
$231K Buy
2,890
+104
+4% +$7.96K 0.02% 130
2019
Q1
$221K Sell
2,786
-545
-16% -$40.8K 0.02% 125
2018
Q4
$243K Buy
3,331
+157
+5% +$11.1K 0.03% 116
2018
Q3
$215K Buy
3,174
+577
+22% +$36.8K 0.02% 131
2018
Q2
$150K Hold
2,597
0.02% 139
2018
Q1
$135K Buy
2,597
+146
+6% +$7.88K 0.01% 154
2017
Q4
$132K Hold
2,451
0.01% 155
2017
Q3
$150K Sell
2,451
-163
-6% -$9.88K 0.02% 125
2017
Q2
$160K Buy
2,614
+251
+11% +$15.3K 0.02% 116
2017
Q1
$143K Sell
2,363
-105
-4% -$6.37K 0.02% 116
2016
Q4
$139K Hold
2,468
0.02% 115
2016
Q3
$147K Sell
2,468
-28
-1% -$1.64K 0.02% 110
2016
Q2
$137K Buy
2,496
+28
+1% +$1.49K 0.02% 122
2016
Q1
$125K Sell
2,468
-524
-18% -$25.7K 0.02% 123
2015
Q4
$151K Sell
2,992
-533
-15% -$26.9K 0.02% 104
2015
Q3
$166K Buy
3,525
+270
+8% +$14.3K 0.03% 94
2015
Q2
$177K Buy
3,255
+524
+19% +$29.4K 0.03% 88
2015
Q1
$150K Sell
2,731
-791
-22% -$44.8K 0.02% 96
2014
Q4
$191K Sell
3,522
-133
-4% -$7.41K 0.03% 91
2014
Q3
$207K Sell
3,655
-760
-17% -$42.7K 0.03% 88
2014
Q2
$244K Sell
4,415
-985
-18% -$53.7K 0.04% 82
2014
Q1
$293K Sell
5,400
-264
-5% -$13.7K 0.05% 79
2013
Q4
$271K Buy
5,664
+970
+21% +$44.3K 0.04% 79
2013
Q3
$213K Sell
4,694
-1,258
-21% -$57.4K 0.04% 83
2013
Q2
$264K Buy
+5,952
New +$266K 0.05% 76

Other funds holding MRK

QCI Asset Management's MRK Position: Q3 2021 in Review

QCI Asset Management increased its Merck (MRK) stake by 0.17% in Q3 2021, buying an estimated $761 and bringing the position to 6,042 shares worth $454K. The position accounts for 0.03% of the portfolio, ranked #99.

QCI Asset Management first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. The position peaked at $531K in Q1 2021. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • QCI Asset Management held 6,042 shares of Merck worth $454K as of Q3 2021.
  • QCI Asset Management bought 10 Merck shares in Q3 2021, an estimated $761.
  • Merck made up 0.03% of QCI Asset Management's portfolio in Q3 2021, its #99 holding.
  • QCI Asset Management first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
  • QCI Asset Management's Merck position peaked at $531K in Q1 2021.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on QCI Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.